Advertisement

Anxiety, Stress, and Neurological Dysfunction: From Basic Biology to Present Therapeutic Interventions

  • Ravindra Pramod DeshpandeEmail author
  • Phanithi Prakash Babu
Chapter

Abstract

Emotion is a way to express the inherent feeling. In present Indian society, psychological disturbance is still considered as stigma and often not rendered proper counseling and emotional help. Presently, we have tried to conceptualize the borders of mental and emotional well-being and how deviations thereof cause the psychological disturbances. The psyche of each individual is molded by the immediate surrounding which may define the internal thresholds to bear the stress. Presence of emotional stress or anxiety as a comorbidity with other diseases as stroke and cancer often goes unnoticed and deserves a special attention and treatment. We also shed light on how internal as well as external factors lead to disturbances of hormones and neurotransmitters causing anxiety and stressful conditions and how present drugs and the cognitive behavioral treatment (CBT) help to alleviate the disease. In addition, traditional ways as mindfulness and heartfulness meditation can help in proper conditioning of mind in turn helping to lead a balanced and stress-free life.

Keywords

Emotion Threshold CBT Stress Neurotransmitter 

References

  1. 1.
    Le Moal M (2007) Historical approach and evolution of the stress concept: a personal account. Psychoneuroendocrinology 32(1):30Google Scholar
  2. 2.
    Selye H (1973) The evolution of the stress concept. Am Sci 61(6):692–699PubMedPubMedCentralGoogle Scholar
  3. 3.
    Johansson L, Guo X, Waern M, Ostling S, Gustafson D, Bengtsson C et al 2010 Midlife psychological stress and risk of dementia: a 35-year longitudinal population study. Brain 133(Pt 8):2217–2224PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Sugama S, Sekiyama K, Kodama T, Takamatsu Y, Takenouchi T, Hashimoto M et al (2016) Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: possible role of chronic stress in the onset of Parkinson’s disease. Brain Behav Immun 51:39–46PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Artemiadis AK, Anagnostouli MC, Alexopoulos EC (2011) Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 36(2):109–120PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Lovera J, Reza T (2013) Stress in multiple sclerosis: review of new developments and future directions. Curr Neurol Neurosci Rep 13(11):013–0398CrossRefGoogle Scholar
  7. 7.
    Alonso J, Liu Z, Evans-Lacko S, Sadikova E, Sampson N, Chatterji S et al (2018) Treatment gap for anxiety disorders is global: results of the World Mental Health Surveys in 21 countries. Depress Anxiety 35(3):195–208PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Lopez AD, Murray CC (1998 Nov) The global burden of disease, 1990-2020. Nat Med 4(11):1241–1243.  https://doi.org/10.1038/3218CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Mauss IB, Robinson MD (2009) Measures of emotion: a review. Cogn Emot 23(2):209–237PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Tang YY, Holzel BK, Posner MI (2015) The neuroscience of mindfulness meditation. Nat Rev Neurosci 16(4):213–225CrossRefGoogle Scholar
  11. 11.
    Lee YS, Hwang J, Kim SJ, Sung YH, Kim J, Sim ME et al (2006) Decreased blood flow of temporal regions of the brain in subjects with panic disorder. J Psychiatr Res 40(6):528–534PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Kent JM, Mathew SJ, Gorman JM (2002) Molecular targets in the treatment of anxiety. Biol Psychiatry 52(10):1008–1030PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Engel K, Bandelow B, Gruber O, Wedekind D (2009) Neuroimaging in anxiety disorders. J Neural Transm 116(6):703–716PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Paus T, Castro-Alamancos MA, Petrides M (2001) Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci 14(8):1405–1411PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A (1999) Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56(4):367–374PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Martin EI, Ressler KJ, Binder E, Nemeroff CB (2009) The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am 32(3):549–575PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Bowery NG (2010) Historical perspective and emergence of the GABAB receptor. Adv Pharmacol 58:1–18PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Sieghart W (2006) Structure, pharmacology, and function of GABAA receptor subtypes. Adv Pharmacol 54:231–263PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Bergink V, van Megen HJ, Westenberg HG (2004) Glutamate and anxiety. Eur Neuropsychopharmacol 14(3):175–183PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Nishi M, Hinds H, Lu HP, Kawata M, Hayashi Y (2001) Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci 21(23):RC185PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Fineberg NA, Brown A, Reghunandanan S, Pampaloni I (2012) Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol 15(8):1173–1191PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Gardoni F, Di Luca M (2006) New targets for pharmacological intervention in the glutamatergic synapse. Eur J Pharmacol 545(1):2–10PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Boldrini M, Underwood MD, Mann JJ, Arango V (2008) Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res 42(6):433–442PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK et al (2007) Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 61(9):1081–1089PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Neumeister A, Young T, Stastny J (2004) Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter. Psychopharmacology 174(4):512–524PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Stahl SM, Grady MM, Moret C, Briley M (2005) SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10(9):732–747PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN et al (2010) British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 24(11):1577–1601PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Ludwig L, Pasman JA, Nicholson T, Aybek S, David AS, Tuck S et al (2018) Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry 5(4):307–320PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Nicholson TR, Aybek S, Craig T, Harris T, Wojcik W, David AS et al (2016) Life events and escape in conversion disorder. Psychol Med 46(12):2617–2626PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Finlay-Jones R, Brown GW (1981) Types of stressful life event and the onset of anxiety and depressive disorders. Psychol Med 11(4):803–815PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    White MG, Bogdan R, Fisher PM, Munoz KE, Williamson DE, Hariri AR (2012) FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity. Genes Brain Behav 11(7):869–878CrossRefGoogle Scholar
  32. 32.
    Sandi C, Davies HA, Cordero MI, Rodriguez JJ, Popov VI, Stewart MG (2003) Rapid reversal of stress induced loss of synapses in CA3 of rat hippocampus following water maze training. Eur J Neurosci 17(11):2447–2456PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Scholey A, Gibbs A, Neale C, Perry N, Ossoukhova A, Bilog V et al (2014) Anti-stress effects of lemon balm-containing foods. Nutrients 6(11):4805–4821PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Song L, Che W, Min-Wei W, Murakami Y, Matsumoto K (2006) Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacol Biochem Behav 83(2):186–193PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ (2001) Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62(2):111–123PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Reiche EM, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5(10):617–625PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Cohen H, Benjamin J, Geva AB, Matar MA, Kaplan Z, Kotler M (2000) Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Res 96(1):1–13PubMedCrossRefGoogle Scholar
  38. 38.
    Vrijkotte TG, van Doornen LJ, de Geus EJ (2000) Effects of work stress on ambulatory blood pressure, heart rate, and heart rate variability. Hypertension 35(4):880–886PubMedCrossRefGoogle Scholar
  39. 39.
    DeBerry JJ, Robbins MT, Ness TJ (2015) The amygdala central nucleus is required for acute stress-induced bladder hyperalgesia in a rat visceral pain model. Brain Res 5:77–85CrossRefGoogle Scholar
  40. 40.
    Ranjbaran M, Mirzaei P, Lotfi F, Behzadi S, Sahraei H (2013) Reduction of metabolic signs of acute stress in male mice by Papaver rhoaes hydro-alcoholic extract. Pak J Biol Sci 16(19):1016–1021PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Kuhnt S, Brahler E, Faller H, Harter M, Keller M, Schulz H et al (2016) Twelve-month and lifetime prevalence of mental disorders in cancer patients. Psychother Psychosom 85(5):289–296PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Mehnert A, Brahler E, Faller H, Harter M, Keller M, Schulz H et al (2014) Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 32(31):3540–3546PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Dahlquist LM, Czyzewski DI, Copeland KG, Jones CL, Taub E, Vaughan JK (1993) Parents of children newly diagnosed with cancer: anxiety, coping, and marital distress. J Pediatr Psychol 18(3):365–376PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Wijnberg-Williams BJ, Kamps WA, Klip EC, Hoekstra-Weebers JE (2006) Psychological adjustment of parents of pediatric cancer patients revisited: five years later. Psychooncology 15(1):1–8PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Barrera M, Atenafu E, Hancock K (2009) Longitudinal health-related quality of life outcomes and related factors after pediatric SCT. Bone Marrow Transplant 44(4):249–256PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Bommakanti K, Gaddamanugu P, Alladi S, Purohit AK, Chadalawadi SK, Mekala S et al (2016) Pre-operative and post-operative psychiatric manifestations in patients with supratentorial meningiomas. Clin Neurol Neurosurg 147:24–29PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103(1):61–76PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A et al (2009) Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol 71(3):299–303PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER (2004) Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery 54(2):358–366PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P (2005) Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 56(6):1234–1241PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13(1):46–51PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    van der Vossen S, Schepers VP, Berkelbach van der Sprenkel JW, Visser-Meily JM, Post MW (2014) Cognitive and emotional problems in patients after cerebral meningioma surgery. J Rehabil Med 46(5):430–437PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Bunevicius A, Deltuva VP, Tamasauskas A (2017) Association of pre-operative depressive and anxiety symptoms with five-year survival of glioma and meningioma patients: a prospective cohort study. Oncotarget 8(34):57543–57551PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P (2013) Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies. Int J Stroke 8(7):545–559PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Grenier S, Schuurmans J, Goldfarb M, Preville M, Boyer R, O’Connor K et al (2011) The epidemiology of specific phobia and subthreshold fear subtypes in a community-based sample of older adults. Depress Anxiety 28(6):456–463PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC (2015) Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther 37(5):984–995PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C (2012) Gamma-aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 113(2):411–417PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Dinan TG, Cryan JF (2012) Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology 37(9):1369–1378PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Dinan TG, Cryan JF (2013) Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil 25(9):713–719PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Bailey MT, Lubach GR, Coe CL (2004) Prenatal stress alters bacterial colonization of the gut in infant monkeys. J Pediatr Gastroenterol Nutr 38(4):414–421PubMedCrossRefGoogle Scholar
  61. 61.
    Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L et al (2012) Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37(11):1885–1895PubMedCrossRefGoogle Scholar
  62. 62.
    Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X et al (2011) The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 23(12):1132–1139PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG (2008) The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 43(2):164–174PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T et al (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155(7):1451–1463PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Musiat P, Tarrier N (2014) Collateral outcomes in e-mental health: a systematic review of the evidence for added benefits of computerized cognitive behavior therapy interventions for mental health. Psychol Med 44(15):3137–3150PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Arico D, Raggi A, Ferri R (2016) Cognitive behavioral therapy for insomnia in breast cancer survivors: a review of the literature. Front Psychol 7:1162PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Morin CM, Benca R (2012) Chronic insomnia. Lancet 379(9821):1129–1141PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Wetherell JL, Gatz M, Craske MG (2003) Treatment of generalized anxiety disorder in older adults. J Consult Clin Psychol 71(1):31–40PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL et al (2018) Antidepressants for insomnia in adults. Cochrane Database Syst Rev 5:CD010753PubMedPubMedCentralGoogle Scholar
  70. 70.
    Shelton RC (2019) Serotonin and norepinephrine reuptake inhibitors. Handb Exp Pharmacol 6:10Google Scholar
  71. 71.
    Tripathi AC, Upadhyay S, Paliwal S, Saraf SK (2018) Privileged scaffolds as MAO inhibitors: retrospect and prospects. Eur J Med Chem 145:445–497PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Harinath K, Malhotra AS, Pal K, Prasad R, Kumar R, Kain TC et al (2004) Effects of Hatha yoga and Omkar meditation on cardiorespiratory performance, psychologic profile, and melatonin secretion. J Altern Complement Med 10(2):261–268CrossRefGoogle Scholar
  73. 73.
    Lang AJ (2017) Mindfulness in PTSD treatment. Curr Opin Psychol 14:40–43PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Davis LW, Strasburger AM, Brown LF (2007) Mindfulness: an intervention for anxiety in schizophrenia. J Psychosoc Nurs Ment Health Serv 45(11):23–29PubMedPubMedCentralGoogle Scholar
  75. 75.
    Moritz S, Cludius B, Hottenrott B, Schneider BC, Saathoff K, Kuelz AK et al (2015) Mindfulness and relaxation treatment reduce depressive symptoms in individuals with psychosis. Eur Psychiatry 30(6):709–714PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Thimmapuram J, Pargament R, Sibliss K, Grim R, Risques R, Toorens E (2017) Effect of heartfulness meditation on burnout, emotional wellness, and telomere length in health care professionals. J Community Hosp Intern Med Perspect 7(1):21–27PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Ravindra Pramod Deshpande
    • 1
    • 2
    Email author
  • Phanithi Prakash Babu
    • 1
  1. 1.Department of Biotechnology and Bioinformatics, School of Life SciencesUniversity of HyderabadHyderabadIndia
  2. 2.Department of Caner BiologyWake Forest School of MedicineWinston SalemUSA

Personalised recommendations